Novartis(US:NVS) Seeking Alpha·2025-10-03 12:56Core Insights - The article emphasizes the continued investment potential in Novartis AG, highlighting a 15% surge in its stock price over the past three months, suggesting it remains a 'Buy' opportunity [1]. Group 1: Company Overview - Novartis AG is positioned as a strong investment option, with a focus on uncovering undervalued assets in the pharmaceutical sector [1]. - The company is part of a broader investment strategy that includes ETFs, commodities, and technology, indicating a diversified approach to investment [1]. Group 2: Investment Philosophy - Allka Research, the entity behind the analysis, adopts a conservative investment strategy aimed at delivering substantial returns and strategic insights [1]. - The mission of Allka Research is to simplify investment strategies, making them accessible to both seasoned and novice investors [1].